KR20230090333A - 조성물 - Google Patents

조성물 Download PDF

Info

Publication number
KR20230090333A
KR20230090333A KR1020237015719A KR20237015719A KR20230090333A KR 20230090333 A KR20230090333 A KR 20230090333A KR 1020237015719 A KR1020237015719 A KR 1020237015719A KR 20237015719 A KR20237015719 A KR 20237015719A KR 20230090333 A KR20230090333 A KR 20230090333A
Authority
KR
South Korea
Prior art keywords
group
compound
polymer
molecular weight
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020237015719A
Other languages
English (en)
Korean (ko)
Inventor
신지 사쿠마
타쿠미 토모노
고헤이 미야타
코이치 시게노
Original Assignee
각코호우징 조쇼 가쿠엔
가부시키가이샤 아데카
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 각코호우징 조쇼 가쿠엔, 가부시키가이샤 아데카 filed Critical 각코호우징 조쇼 가쿠엔
Publication of KR20230090333A publication Critical patent/KR20230090333A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F222/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
    • C08F222/36—Amides or imides
    • C08F222/38—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
KR1020237015719A 2020-10-16 2021-10-11 조성물 Pending KR20230090333A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP-P-2020-174704 2020-10-16
JP2020174704 2020-10-16
PCT/JP2021/037523 WO2022080294A1 (ja) 2020-10-16 2021-10-11 組成物

Publications (1)

Publication Number Publication Date
KR20230090333A true KR20230090333A (ko) 2023-06-21

Family

ID=81208159

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020237015719A Pending KR20230090333A (ko) 2020-10-16 2021-10-11 조성물

Country Status (6)

Country Link
US (1) US20230383037A1 (cg-RX-API-DMAC7.html)
EP (1) EP4230223A4 (cg-RX-API-DMAC7.html)
JP (1) JPWO2022080294A1 (cg-RX-API-DMAC7.html)
KR (1) KR20230090333A (cg-RX-API-DMAC7.html)
CN (1) CN116507364A (cg-RX-API-DMAC7.html)
WO (1) WO2022080294A1 (cg-RX-API-DMAC7.html)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010502667A (ja) 2006-09-07 2010-01-28 エフ.ホフマン−ラ ロシュ アーゲー Snac(サルカプロザートナトリウム)の製造法
WO2010134537A1 (ja) 2009-05-20 2010-11-25 東レ株式会社 細胞膜透過性ペプチド
WO2016136708A1 (ja) 2015-02-27 2016-09-01 学校法人常翔学園 膜透過性ペプチドを側鎖に有する高分子化合物
JP2019522020A (ja) 2016-04-06 2019-08-08 イファ ユニバーシティ−インダストリー コラボレーション ファウンデーションEwha University − Industry Collaboration Foundation 細胞膜に浸透する能力を有するペプチド

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4099831B2 (ja) 1994-07-14 2008-06-11 昭和電工株式会社 高重合性n−ビニルカルボン酸アミドおよびその製造方法
JP5281358B2 (ja) * 2008-10-27 2013-09-04 学校法人常翔学園 高分子、経上皮吸収促進剤、及び医薬用製剤
JP5808082B2 (ja) * 2010-04-30 2015-11-10 株式会社Adeka 細胞への水溶性高分子量物質の導入方法及び導入剤
CN107207627B (zh) * 2015-02-27 2022-05-24 学校法人常翔学园 具有膜透过性肽链的多糖衍生物
KR102879868B1 (ko) * 2018-07-11 2025-10-31 각코호우징 조쇼 가쿠엔 고분자 화합물 및 이를 이용한 세포내 화합물 도입 촉진제

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010502667A (ja) 2006-09-07 2010-01-28 エフ.ホフマン−ラ ロシュ アーゲー Snac(サルカプロザートナトリウム)の製造法
WO2010134537A1 (ja) 2009-05-20 2010-11-25 東レ株式会社 細胞膜透過性ペプチド
WO2016136708A1 (ja) 2015-02-27 2016-09-01 学校法人常翔学園 膜透過性ペプチドを側鎖に有する高分子化合物
JP2019522020A (ja) 2016-04-06 2019-08-08 イファ ユニバーシティ−インダストリー コラボレーション ファウンデーションEwha University − Industry Collaboration Foundation 細胞膜に浸透する能力を有するペプチド

Also Published As

Publication number Publication date
EP4230223A1 (en) 2023-08-23
JPWO2022080294A1 (cg-RX-API-DMAC7.html) 2022-04-21
EP4230223A4 (en) 2025-03-05
US20230383037A1 (en) 2023-11-30
WO2022080294A1 (ja) 2022-04-21
CN116507364A (zh) 2023-07-28

Similar Documents

Publication Publication Date Title
KR20140002594A (ko) 면역억제 조절 화합물
JP2745351B2 (ja) ペプチド誘導体及びその用途
JP2022058911A (ja) 非血液凝固タンパク質の糖ポリシアル酸化
JP2013500375A (ja) 非血液凝固タンパク質の糖ポリシアル酸化
KR20030031502A (ko) 디디에스 화합물 및 그의 제조방법
JP2022502392A (ja) 経口剤形の製造方法
US10501564B2 (en) Polymer compound which has membrane-permeable peptide in side chain
EP3577217B1 (en) Retargeting of viruses or vlps
US10793603B2 (en) Polysaccharide derivative having membrane-permeable peptide chain
US20060241022A1 (en) Selectin targeting bioconjugates
JP2009149728A (ja) ポリエーテルの製造方法
JP2008543304A (ja) ヒト顆粒球コロニー刺激因子イソ型(HumanGranulocyte−ColonyStimulatingFactorIsoforms)
US20230383037A1 (en) Composition
CN120077136A (zh) 抑制淀粉样前体蛋白(APP)基因表达的siRNA、药物及其应用
JP7432208B2 (ja) 高分子化合物及びそれを用いた細胞内化合物導入促進剤
WO2009103199A1 (zh) 水溶性聚合物修饰的g-csf偶联物
CN101220084A (zh) 聚乙二醇修饰的三价铁亚血红素短肽化合物及制备方法
CN101172161A (zh) 水溶性聚合物修饰的g-csf偶联物
CN113164613B (zh) 二聚的肽-磷脂缀合物的优化方法
JP2015124162A (ja) フェノール性水酸基を有するhsp90阻害剤のアクティブターゲティング型高分子誘導体及びその用途
KR20250117319A (ko) 미토콘드리아 기능 개선 펩타이드의 항암 용도
WO2026002308A1 (zh) 靶向her2的多肽偶联药物及其制备方法和应用

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

D21 Rejection of application intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902